Latigo Biotherapeutics Inc. (LTGO)
LTGO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$15.71
-1.94% on the day
Market cap
$1.0B
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | LTGO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002056611 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-08-07 |
| Latest quarterly / interim | 10-Q | 2026-09-03 |
| Latest current report | 8-K | 2026-09-03 |
Source: SEC EDGAR submissions feed, 40 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.3% |
| 1 month | -38.1% |
| 3 months | Not enough price history |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -43.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| JANX | Janux Therapeutics Inc. | $17.18 | -5.34% | $1.1B |
| AVLN | Avalyn Pharma Inc. | $23.74 | -4.27% | $1.1B |
| HROW | Harrow Inc. | $28.24 | -2.99% | $1.1B |
| NBTX | Nanobiotix S.A. | $21.49 | -8.16% | $1.1B |
| OPK | OPKO Health Inc. | $1.32 | -4.35% | $985.2M |
| SVRA | Savara Inc. | $4.78 | -1.24% | $982.1M |
| MNKD | MannKind Corporation | $3.05 | -2.56% | $980.7M |
| AMPH | Amphastar Pharmaceuticals Inc. | $26.05 | -2.65% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier